FDA Approves Voceryq for Recurrent Respiratory Papillomatosis – respiratory
FDA Approves Voceryq for Recurrent Respiratory Papillomatosis respiratory-therapy.com
2026
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections Patient Care Online
Generic Venetoclax Gains Final FDA Approval in CLL/SLL and Newly Diagnosed AML
Generic Venetoclax Gains Final FDA Approval in CLL/SLL and Newly Diagnosed AML OncLive
NeuroVoices: Cindy Zadikoff, MD, MSc, on the FDA Approval of Tavapadon for Parkinson Disease
NeuroVoices: Cindy Zadikoff, MD, MSc, on the FDA Approval of Tavapadon for Parkinson Disease NeurologyLive